0001209191-22-012743.txt : 20220224
0001209191-22-012743.hdr.sgml : 20220224
20220224170444
ACCESSION NUMBER: 0001209191-22-012743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220223
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornfeld Steven
CENTRAL INDEX KEY: 0001814653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 22672214
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-23
0
0001419041
Forte Biosciences, Inc.
FBRX
0001814653
Kornfeld Steven
C/O FORTE BIOSCIENCES, INC.
3060 PEGASUS PARK DR., BUILDING 6
DALLAS
TX
75247
1
0
0
0
Stock Option (right to buy)
1.27
2022-02-23
4
A
0
25000
0.00
A
2032-02-23
Common Stock
25000
25000
D
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant. "Date of Grant" shall mean February 23, 2022.
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2022-02-24